03:46 PM EST - Nuvo Research Inc. : Announced that the United States Patent Office has granted U.S. patent no. 9,107,823 ('823 Patent) covering novel topical foam formulations that include dimethyl sulfoxide (DMSO) together with certain drug actives. Nuvo has pioneered the use of DMSO as a carrier in topically-applied drug products which is a key component of the Company's U.S. Food and Drug Administration (FDA) approved products, Pennsaid® and Pennsaid 2%. Nuvo Research Inc.
shares T.NRI are trading down $0.01 at $5.34.
